Profile data is unavailable for this security.
About the company
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (68 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, Aledex, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revyve are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
- Revenue in CAD (TTM)757.12k
- Net income in CAD-5.48m
- Incorporated2003
- Employees--
- LocationKane Biotech Inc290-100 Innovation DriveWINNIPEG R3T 6G2CanadaCAN
- Phone+1 (204) 453-1301
- Fax+1 (204) 474-7552
- Websitehttps://kanebiotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crescita Therapeutics Inc | 16.84m | -2.98m | 11.41m | 80.00 | -- | 0.6659 | -- | 0.6775 | -0.150 | -0.150 | 0.8486 | 0.8861 | 0.6808 | 1.44 | 5.54 | 210,525.00 | -12.06 | -0.2457 | -15.07 | -0.3059 | 54.66 | 63.41 | -17.72 | -0.3518 | 2.32 | -- | 0.0568 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
| Willow Biosciences Inc | 1.84m | -8.70m | 13.70m | 19.00 | -- | -- | -- | 7.45 | -0.0695 | -0.0695 | 0.0147 | -0.0004 | 0.249 | -- | 111.52 | 96,842.10 | -117.73 | -- | -164.04 | -- | -- | -- | -472.83 | -- | 0.6479 | -- | 1.03 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
| Cytophage Technologies Ltd | 0.00 | -7.80m | 15.10m | -- | -- | 2.86 | -- | -- | -0.3779 | -0.3779 | 0.00 | 0.0978 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2374 | -- | -- | -- | -25.88 | -- | -- | -- |
| Kane Biotech Inc | 757.12k | -5.48m | 17.80m | -- | -- | -- | -- | 23.51 | -0.042 | 0.0374 | 0.0059 | -0.0055 | 0.1568 | 0.3751 | 3.23 | -- | -113.43 | -77.89 | -- | -- | 60.54 | 43.27 | -723.31 | -241.85 | 0.5679 | -4.73 | 1.43 | -- | -94.42 | -20.26 | -17.29 | -- | -19.41 | -- |
| Pharmacielo Ltd | 1.62m | -14.15m | 19.52m | 268.00 | -- | -- | -- | 12.05 | -0.0849 | -0.0849 | 0.0097 | -0.032 | 0.0699 | 1.38 | 24.15 | -- | -61.03 | -- | -165.82 | -- | -86.39 | -- | -873.57 | -- | 0.039 | -2.48 | 1.37 | -- | -70.96 | -- | -12.27 | -- | -- | -- |
| Avricore Health Inc | 4.48m | -2.92k | 19.68m | -- | -- | 8.55 | 41.77 | 4.40 | -0.00006 | -0.00006 | 0.0443 | 0.0228 | 1.88 | -- | 17.32 | -- | -0.1226 | -85.75 | -0.1437 | -142.65 | 36.16 | 31.65 | -0.0652 | -116.09 | 2.76 | -0.6508 | 0.00 | -- | 97.08 | 196.15 | 14.30 | -- | 80.26 | -- |
| Devonian Health Group Inc | 9.75m | -3.17m | 23.72m | 6.00 | -- | 1.78 | -- | 2.43 | -0.0216 | -0.0216 | 0.0665 | 0.09 | 0.4423 | 33.07 | 2.32 | 1,625,238.00 | -14.37 | -21.02 | -23.15 | -23.96 | 30.95 | 29.96 | -32.50 | -131.97 | 1.06 | -9.41 | 0.1406 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |
| Immunoprecise Antibodies Ltd | 24.09m | -27.61m | 24.99m | 102.00 | -- | 0.7605 | -- | 1.04 | -0.7695 | -0.7695 | 0.6794 | 0.8876 | 0.3546 | 6.12 | 6.16 | -- | -40.63 | -26.70 | -46.68 | -30.31 | 48.21 | 56.13 | -114.58 | -85.72 | 0.8189 | -134.72 | 0.3289 | -- | 18.65 | 17.54 | -2.32 | -- | 16.71 | -- |
